Janiczek Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $960K | Buy |
6,728
+290
| +5% | +$41.4K | 0.2% | 46 |
|
|
2024
Q1 | $828K | Buy |
6,438
+576
| +10% | +$74K | 0.18% | 52 |
|
|
2023
Q4 | $606K | Buy |
5,862
+143
| +3% | +$14.8K | 0.15% | 62 |
|
|
2023
Q3 | $520K | Buy |
5,719
+89
| +2% | +$8.09K | 0.14% | 63 |
|
|
2023
Q2 | $456K | Buy |
5,630
+104
| +2% | +$8.42K | 0.13% | 62 |
|
|
2023
Q1 | $466K | Sell |
5,526
-36
| -0.6% | -$3.04K | 0.13% | 56 |
|
|
2022
Q4 | $372K | Buy |
5,562
+190
| +4% | +$12.7K | 0.1% | 68 |
|
|
2022
Q3 | $279K | Sell |
5,372
-298
| -5% | -$15.5K | 0.09% | 71 |
|
|
2022
Q2 | $329K | Sell |
5,670
-542
| -9% | -$31.4K | 0.1% | 66 |
|
|
2022
Q1 | $345K | Buy |
6,212
+646
| +12% | +$35.9K | 0.1% | 68 |
|
|
2021
Q4 | $312K | Buy |
5,566
+302
| +6% | +$16.9K | 0.09% | 72 |
|
|
2021
Q3 | $253K | Buy |
5,264
+366
| +7% | +$17.6K | 0.09% | 74 |
|
|
2021
Q2 | $205K | Buy |
4,898
+40
| +0.8% | +$1.67K | 0.07% | 81 |
|
|
2021
Q1 | $164K | Buy |
4,858
+1,812
| +59% | +$61.2K | 0.07% | 82 |
|
|
2020
Q4 | $106K | Buy |
3,046
+1,764
| +138% | +$61.4K | 0.05% | 100 |
|
|
2020
Q3 | $45K | Buy |
+1,282
| New | +$45K | 0.02% | 104 |
|